A pilot study of the association of manganese superoxide dismutase and glutathione peroxidase 1 single gene polymorphisms with prostate cancer and serum prostate specific antigen levels
    
Yazarlar (7)
Prof. Dr. Bekir Süha PARLAKTAŞ Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Doğan ATILĞAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Yusuf Gencten
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ismail Benli
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Hüseyin Ozyurt
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Nihat ULUOCAK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Fikret ERDEMİR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Archives of Medical Science (Q4)
Dergi ISSN 1734-1922 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2015
Cilt / Sayı / Sayfa 11 / 5 / 994–1000 DOI 10.5114/aoms.2015.54853
Özet
Results: No association was found between GPX1 polymorphisms and PCa in all groups (p> 0.05). In the PCa group, the frequency of homozygote Val allele carriers was significantly higher in comparison to nonPCa-high PSA control cases. Therefore, Val/Val genotype was found significantly suspicious for PCa risk (OR= 2.48; 95% CI: 1.37–4.48; p= 0.002). Furthermore, an overall protective effect of the Ala allele of the MnSOD polymorphism on PCa risk was detected. These findings in this small Turkish population suggested that individual risk of PCa may be modulated by MnSOD polymorphism especially in patients with high PSA, but GPX1 polymorphism seemed to have no effect on PCa risk.Conclusions: The presence of genetic variants of antioxidant enzymes could have a potential influence on genesis of prostatic malignancy.
Anahtar Kelimeler
Antioxidant enzymes | Genetic polymorphism | Glutathione peroxidase 1 | Manganese superoxide dismutase | Prostate cancer